摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (2Z)-3-chloro-2-cyano-4,4,4-trifluorobut-2-enoate | 148836-73-1

中文名称
——
中文别名
——
英文名称
methyl (2Z)-3-chloro-2-cyano-4,4,4-trifluorobut-2-enoate
英文别名
2-chloro-1-cyano-1-methoxycarbonyl-2-trifluoromethylethylene;methyl (Z)-3-chloro-2-cyano-4,4,4-trifluorobut-2-enoate
methyl (2Z)-3-chloro-2-cyano-4,4,4-trifluorobut-2-enoate化学式
CAS
148836-73-1
化学式
C6H3ClF3NO2
mdl
——
分子量
213.544
InChiKey
XVJNQOQOGOJSLW-ARJAWSKDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    50.1
  • 氢给体数:
    0
  • 氢受体数:
    6

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] HETEROCYCLIC COMPOUNDS AS DELTA-5 DESATURASE INHIBITORS AND METHODS OF USE<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES UTILISÉS EN TANT QU'INHIBITEURS DE DELTA-5 DÉSATURASE ET PROCÉDÉS D'UTILISATION
    申请人:AMGEN INC
    公开号:WO2021108404A1
    公开(公告)日:2021-06-03
    The present disclosure provides compounds useful for the inhibition of Delta-5 Desaturase ("D5D"). The compounds have a general Formula (I): wherein the variables of Formula (I) are defined herein. This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, a metabolic or cardiovascular disorder. Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula (I).
    本公开提供了用于抑制Delta-5 Desaturase ("D5D")的化合物。这些化合物具有一般的化学式(I):其中化学式(I)中的变量在此处定义。本公开还提供了包括这些化合物的药物组合物,这些化合物的用途,以及用于治疗代谢或心血管疾病等疾病的组合物。此外,本公开提供了在合成化学式(I)化合物中有用的中间体。
  • PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS AS CB1 RECEPTOR ANTAGONIST
    申请人:Tanimoto Koichi
    公开号:US20090258867A1
    公开(公告)日:2009-10-15
    The present invention provides a pyrazolo[1,5-a]pyrimidine compound, having CB1 receptor-antagonizing activity, of the following formula [I]: in which R 1 and R 2 are the same or different and each an optionally substituted aryl group etc, R 0 is hydrogen atom, an alkyl group etc, E is a group of the formula: —C(═O)— or —SO 2 —, R is a group of the following formula [i], [ii] or [iii] etc: Ring A is (a) a C 3-8 cycloalkyl group optionally fused to a benzene ring or (b) a benzene ring, Q is a single bond or a methylene group, Ring B is a 4- to 7-membered aliphatic heterocyclic group, said cyclic group binding via its ring-carbon atom to the adjacent nitrogen atom, X is sulfur atom etc, R 3 is an alkyl group optionally substituted by an alkylthio group, R 4 is hydrogen atom, an alkyl group etc, one of R A and R B is an alkyl group etc, and the other is hydrogen atom, an alkyl group etc, or a pharmaceutically acceptable salt thereof.
    本发明提供了一种具有CB1受体拮抗活性的吡唑并[1,5-a]嘧啶化合物,其化学式[I]如下:其中,R1和R2相同或不同,分别是可选取代的芳基等;R0是氢原子,烷基等;E是以下式子的基团:—C(═O)—或—SO2—;R是以下式子[i]、[ii]或[iii]等的基团:环A是(a)一个C3-8环烷基,可选地融合到苯环上,或(b)一个苯环;Q是单键或亚甲基基团;环B是一个4-7个成员的脂肪族杂环基团,该环基团通过其环碳原子与相邻的氮原子结合;X是原子等;R3是可选取代的烷基,可以是烷基基等;R4是氢原子,烷基等;RA和RB中的一个是烷基等,另一个是氢原子,烷基等,或其药学上可接受的盐。
  • Pyrazolo[1,5-A]Pyrimidine Compounds
    申请人:Moritani Yasunori
    公开号:US20090069298A1
    公开(公告)日:2009-03-12
    The present invention relates to a novel pyrazolo[1,5-a]pyrimidine compound of the formula [I]: wherein R 1 and R 2 are the same or different and an optionally substituted aryl group etc. Q is single bond, a methylene group or a group of the formula: —N(R Q )—, R Q is an alkyl group, Ring A is a substituted pyrazole ring fused to the adjacent pyrimidine ring having the following formula (A), (B) or (C), R 3 and R 4 are the same or different and a hydrogen atom, a cyano group etc. E is one of the following groups (i) to (v): R 00 is an alkyl group, Q 1 is a single bond etc., Q 2 is a single bond or an alkylene group, one of R 5 and R 6 is a hydrogen atom or an alkyl group and the other is an alkyl group etc., one of R 50 and R 60 is a hydrogen atom or an alkyl group and the other is a hydrogen atom, an alkyl group etc., R 51 is an alkyl group or an optionally substituted arylsulfonyl group, R 61 is an alkylamino group or an azido group, or a pharmaceutically acceptable salt thereof.
    本发明涉及一种新型吡唑并[1,5-a]嘧啶化合物,其化学式为[I]:其中R1和R2相同或不同,可以是任选取代芳基等;Q是单键,亚甲基基团或式子:—N(RQ)—,RQ是烷基基团;环A是一个取代的吡唑环与相邻的嘧啶环融合,具有以下式子(A)、(B)或(C):其中R3和R4相同或不同,可以是氢原子、基等;E是以下式子(i)至(v)中的一种:其中R00是烷基基团,Q1是单键等,Q2是单键或烷基烃基团,R5和R6中的一个是氢原子或烷基基团,另一个是烷基基团等,R50和R60中的一个是氢原子或烷基基团,另一个是氢原子、烷基基团等,R51是烷基基团或任选取代的芳基磺酰基团,R61是烷基基基团或叠氮基团,或其药学上可接受的盐。
  • Pesticidal method using N-phenylpyrazoles
    申请人:RHONE-POULENC AGROCHIMIE
    公开号:EP0234119A1
    公开(公告)日:1987-09-02
    The invention provides a method for the control of arthropod, plant nematode or helminth pests using compounds of the formula: wherein Y is halogen, cyano, nitro, RSO₂, RSO or RS in which R is alkyl, cycloalkyl or alkenyl, thiocyanato, sulphamoyl, carbamoyl, alkoxycarbonyl, alkanoyl or alkyl; Z represents hydrogen, an amino group -NR¹R², alkylsulphenylamino, alkoxymethyleneamino, halogen, alkyl, carboxy, alkylthio, alkylsulphinyl or alkylsulphonyl, trialkylsilylmethyl, trialkylsilyl, cyano or nitro; R³ represents halogen, alkyl or alkoxy, halogen-substituted alkylthio or alkylsulphinyl, nitro, cyano, or alkylsulphonyl; and R⁴ represents halogen, cyano, nitro, alkyl or cycloalkyl, and n is 1 to 5, and salts thereof, provided that R⁴, Y and Z do not simultaneously represent one of nitro, cyano, halogen and unsubstituted alkyl; pesticidal compositions, novel compounds and processes for their preparation are described.
    本发明提供了一种使用式化合物防治节肢动物、植物线虫或蠕虫害虫的方法: 其中 Y 是卤素、基、硝基、RSO₂、RSO 或 RS,其中 R 是烷基、环烷基或烯基、基、基磺酰基、基甲酰基、烷氧基羰基、烷酰基或烷基;Z 代表氢、基-NR¹R²、烷基代苯基、烷氧基亚甲基基、卤素、烷基、羧基、烷基、烷基亚磺酰基或烷基磺酰基、三烷基甲基、三烷基基、基或硝基;R³ 代表卤素、烷基或烷氧基、卤素取代的烷基或烷基亚磺酰基、硝基、基或烷基磺酰基;R⁴ 代表卤素、基、硝基、烷基或环烷基,且 n 为 1 至 5,以及它们的盐,条件是 R⁴、Y 和 Z 不同时代表硝基、基、卤素和未取代烷基中的一种;描述了杀虫剂组合物、新型化合物及其制备工艺。
  • Pyrazolo[1,5-a]pyrimidine compounds as CB1 receptor antagonists
    申请人:Mitsubishi Tanabe Pharma Corporation
    公开号:EP2520577A1
    公开(公告)日:2012-11-07
    The present invention provides pyrazolo[1,5-a]pyrimidine compounds and pharmaceutically acceptable salts thereof having CB1 receptor-antagonizing activity. These compounds, and compositions comprising the same, are hence useful in the treatment of a wide range of conditions and diseases.
    本发明提供了具有 CB1 受体拮抗活性的吡唑并[1,5-a]嘧啶化合物及其药学上可接受的盐类。这些化合物及其组合物可用于治疗多种病症和疾病。
查看更多